BenevolentAI announces strategic plan to boost AI and biopharma businesses
AMSTERDAM: BenevolentAI, a leader that combines cutting-edge Artificial Intelligence (AI) and science to accelerate biopharma discovery and development, today announced a strategic review approved by its Board of Directors. The Company said it is further evolving its differentiated technology platform…